Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Dick Chan; Esther Ooi; Gerald Watts; Hugh Barrett; Seng Gan

doi:10.2337/dc09-1765

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Dick Chan, Esther Ooi, Gerald Watts, Hugh Barrett, Seng Gan

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1134-1139
Journal	Diabetes Care
Volume	33
DOIs	https://doi.org/10.2337/dc09-1765
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc09-1765

Cite this

@article{08b9f7cb9d424fde95cc518277ae243e,

title = "Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet",

author = "Dick Chan and Esther Ooi and Gerald Watts and Hugh Barrett and Seng Gan",

year = "2010",

doi = "10.2337/dc09-1765",

language = "English",

volume = "33",

pages = "1134--1139",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

}

TY - JOUR

T1 - Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

AU - Chan, Dick

AU - Ooi, Esther

AU - Watts, Gerald

AU - Barrett, Hugh

AU - Gan, Seng

PY - 2010

Y1 - 2010

U2 - 10.2337/dc09-1765

DO - 10.2337/dc09-1765

M3 - Article

C2 - 20185740

SN - 0149-5992

VL - 33

SP - 1134

EP - 1139

JO - Diabetes Care

JF - Diabetes Care

ER -